EUVIMEDEUVIMED entdecken
Crossref

Distinct transcriptional and prognostic impacts of TERT promoter mutations C228T and C250T in papillary thyroid carcinoma

Vicente Rodrigues Marczyk iD, Ana Luiza Maia, Iuri Martin Goemann iD

Endocrine-Related Cancer · 2024

DOI: 10.1530/erc-24-0058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2024. Verfasst von Vicente Rodrigues Marczyk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Thyroid Unit, Endocrine division, Hospital de Clínicas de Porto Alegre (HCPA), Brazil. Hauptthemen laut MEDLINE: Telomerase, Thyroid Cancer, Papillary, Promoter Regions, Genetic, Mutation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TERT promoter mutations C228T and C250T are associated with disease aggressiveness and poor clinical outcomes in patients with papillary thyroid carcinomas. However, very little is known about the transcriptional consequences of these mutations and whether they both carry similar oncogenic potential. Here we characterized the transcriptional disturbances and clinical outcomes associated with the presence of each of these two mutations using data derived from The Cancer Genome Atlas. We observed that tumors harboring the C228T mutation ( n = 27) exhibited a 16-fold increase in TERT mRNA levels ( P = 5.3 × 10 −42 ), whereas C250T tumors ( n = 8) showed only a two-fold increase in expression ( P = 0.034). The C228T mutation was associated with the activation of signaling pathways controlling the cell cycle, cellular division, and extracellular matrix degradation. Univariate analysis demonstrated that the C228T mutation was associated with older age at diagnosis, large tumor size, lymph node invasion, and distant metastases at diagnosis. The C228T mutation was also associated with worse progression-free interval (PFI) in comparison to WT tumors (HR = 5,04; P < 0.001). This association remained significant in a multivariate analysis (HR = 3.74, P = 0.003) adjusting for BRAF -V600E status and ATA risk group. Our data indicate that TERT promoter mutations C228T and C250T have distinct transcriptional consequences in papillary thyroid carcinoma (PTC), suggesting a greater oncogenic potential for the C228T mutation. TERT promoter mutation C228T may be a useful prognostic marker to identify patients at high risk of distant recurrence. Clinical data for the C250T mutation is still limited, with no evidence up to date to confirm its prognostic significance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseThyroid Cancer, PapillaryPromoter Regions, GeneticMutationThyroid NeoplasmsHumansPrognosisFemaleMaleMiddle AgedAdultAged

Stichwörter der Autor:innen

TERTTERT promoterpapillary thyroid carcinomasprognosistelomerase reverse transcriptasethyroid carcinomasthyroid neoplasms

Substanzen

TelomeraseTERT protein, human

Autor:innen und Institutionen

  • Thyroid Unit, Endocrine division, Hospital de Clínicas de Porto Alegre (HCPA), Brazil.
  • Medical School, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil.
  • Medical School, Universidade do Vale do Rio dos Sinos (UNISINOS), Brazil.

ORCID-Profile: Vicente Rodrigues Marczyk, Iuri Martin Goemann

Zitieren

APA

Marczyk, V. R., Maia, A. L., & Goemann, I. M. (2024). Distinct transcriptional and prognostic impacts of TERT promoter mutations C228T and C250T in papillary thyroid carcinoma. Endocrine-Related Cancer. https://doi.org/10.1530/erc-24-0058

Vancouver

Marczyk VR, Maia AL, Goemann IM. Distinct transcriptional and prognostic impacts of TERT promoter mutations C228T and C250T in papillary thyroid carcinoma. Endocrine-Related Cancer. 2024. doi:10.1530/erc-24-0058

BibTeX
@article{Marczyk2024,
  author = {Marczyk, Vicente Rodrigues and Maia, Ana Luiza and Goemann, Iuri Martin},
  title = {Distinct transcriptional and prognostic impacts of TERT promoter mutations C228T and C250T in papillary thyroid carcinoma},
  journal = {Endocrine-Related Cancer},
  year = {2024},
  doi = {10.1530/erc-24-0058}
}
Kostenlos starten →